Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Ependymoma × trofosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Medulloblastoma 1 Ependymoma 1 Brain Neoplasms 1

Interventions

Temozolomide 13 Filgrastim 7 Carboplatin 7 Magnetic Resonance Spectroscopy 6 Etoposide 6 Bevacizumab 6 Radiotherapy 5 Cyclophosphamide 5 Cisplatin 5 Thiotepa 4 sargramostim 3 Vincristine 3 Surveys and Questionnaires 3 Peripheral Blood Stem Cell Transplantation 3 Methotrexate 3 Lapatinib 3 Irinotecan 3 Carmustine 3 veliparib 2 alovudine 2 Paclitaxel 2 Mental Status and Dementia Tests 2 Imatinib Mesylate 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Everolimus 2 Donepezil 2 Chemotherapy, Adjuvant 2 Biopsy 2 Azacitidine 2 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00749723 2018-07-20

HIT-REZ-2005

University Hospital, Bonn

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡